Enliven Therapeutics Inc (ELVN)

Date: O: H: L: C: Vol:

Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	33.73%37.21	27.82	34.29	25.10	28.58
Research and Development	40.17%29.00	20.69	21.25	18.23	21.49
Operating Income/Loss	33.73%-37.21	-27.82	-34.29	-25.10	-28.58
Nonoperating Income/Loss	12.58%4.72	4.20	4.62	4.95	3.25
	37.49%-32.49	-23.63	-29.67	-20.15	-25.34
Attributable To Parent	37.49%-32.49	-23.63	-29.67	-20.15	-25.34
Basic Average Shares	5.37%66.17	62.80	1.87	62.09	52.11
Diluted Average Shares	5.37%66.17	62.80	1.87	62.09	52.11
Basic Earnings Per Share	28.95%-0.49	-0.38	-0.48	-0.32	-0.49
Diluted Earnings Per Share	28.95%-0.49	-0.38	-0.48	-0.32	-0.49